Industries

Showing 8331–8340 of 8556 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Rabeprazole Market in China 2021

  The rabeprazole market in China in terms of revenue is set to grow by US$ 860 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 12.7% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the rabeprazole market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Repaglinide Market in China 2021

  The repaglinide market in China in terms of revenue is set to grow by US$ 277 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the repaglinide market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Tigecycline Market in China 2021

  The tigecycline market in China in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 24.8% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the tigecycline market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Decitabine Market in China 2021

  The decitabine market in China in terms of revenue is set to grow by US$ 665 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 22.5% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the decitabine market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Iimatinib Mesylate Market in China 2021

  The iImatinib mesylate market in China in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 22.9% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the iImatinib mesylate market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Gemcitabine Hydrochloride Drugs Market in China 2021

  The gemcitabine hydrochloride drugs market in China in terms of revenue is set to grow by US$ 281 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 11.4% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the gemcitabine hydrochloride drugs market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Olanzapine Drugs Market in China 2021

  The olanzapine drugs market in China in terms of revenue is set to grow by US$ 503 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 11.7% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the olanzapine drugs market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Sintered NdFeB Magnetic Material Market in China 2021

  In terms of volume, the sintered NdFeB magnetic material market in China is expected to grow at a compound annual growth rate (CAGR) of 5.8% over the analysis period of 2021 to 2027, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the sintered NdFeB magnetic material market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Fashion Menswear Retail Market in China 2021

  The fashion menswear retail market in China in terms of revenue is set to grow by US$ 22 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the fashion menswear retail market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Menswear Retail Market in China 2021

  The menswear retail market in China in terms of revenue is set to grow by US$ 71 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the menswear retail market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450